Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aspira Women's Health (AWH)
NASDAQ:AWH
Holding AWH?
Track your performance easily
AWH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.67 - $5.65
Previous Close$0.73
Volume34.00K
Average Volume (3M)93.54K
Market Cap
$11.44M
Enterprise Value$11.45M
Total Cash (Recent Filing)$2.13M
Total Debt (Recent Filing)$2.14M
Price to Earnings (P/E)―
Beta1.06
Next Earnings
Mar 27, 2025EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.20
Shares Outstanding16,667,255
10 Day Avg. Volume72,588
30 Day Avg. Volume93,536
Standard Deviation0.30
R-Squared0.06
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-3.17
Price to Sales (P/S)1.28
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.27
Enterprise Value/Gross Profit2.18
Enterprise Value/Ebitda-0.73
Forecast
1Y Price Target
$3.00Price Target Upside301.18% Upside
Rating ConsensusHold
Number of Analyst Covering1
Aspira Women's Health News
PremiumCompany Announcements
Aspira Women’s Health Reports Q3 2024 Growth and Strategic Advances
PremiumCompany Announcements
Aspira Women’s Health Highlights Future Product Developments
PremiumCompany Announcements
Aspira Women’s Health Engages Investors with Performance InsightsOwnership Overview
19.17% Insiders
2.11% Mutual Funds
8.03% Other Institutional Investors
68.94% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
AWH FAQ
What was Aspira Women's Health’s price range in the past 12 months?
Aspira Women's Health lowest stock price was $0.67 and its highest was $5.65 in the past 12 months.
What is Aspira Women's Health’s market cap?
Currently, no data Available
When is Aspira Women's Health’s upcoming earnings report date?
Aspira Women's Health’s upcoming earnings report date is Mar 27, 2025 which is in 125 days.
How were Aspira Women's Health’s earnings last quarter?
Aspira Women's Health released its earnings results on Nov 14, 2024. The company reported -$0.281 earnings per share for the quarter, missing the consensus estimate of -$0.258 by -$0.023.
Is Aspira Women's Health overvalued?
According to Wall Street analysts Aspira Women's Health’s price is currently Undervalued.
Does Aspira Women's Health pay dividends?
Aspira Women's Health does not currently pay dividends.
What is Aspira Women's Health’s EPS estimate?
Aspira Women's Health’s EPS estimate is -$0.23.
How many shares outstanding does Aspira Women's Health have?
Aspira Women's Health has 16,667,255 shares outstanding.
What happened to Aspira Women's Health’s price movement after its last earnings report?
Aspira Women's Health reported an EPS of -$0.281 in its last earnings report, missing expectations of -$0.258. Following the earnings report the stock price went down -9.756%.
Which hedge fund is a major shareholder of Aspira Women's Health?
Among the largest hedge funds holding Aspira Women's Health’s share is Oracle Investment Management Inc. It holds Aspira Women's Health’s shares valued at N/A.
---
Aspira Women's Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.00 (301.18% Upside)
$3.00 (301.18% Upside)
Hedge Fund Trend
Decreased
By 48.5K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-78.46%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-45.06%
Trailing 12-Months
Company Description
Aspira Women's Health
Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. The company's bio-analytical solutions helps physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion was founded on December 9, 1993 and is headquartered in Austin, TX.
---
AWH Earnings Call
Q3 2024
0:00 / 0:00
---
AWH Stock 12 Month Forecast
Average Price Target
$3.00
▲(301.18% Upside)
Technical Analysis
Best Analysts Covering AWH
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-74.75%
reiterated a buy rating 10 months ago
Copying Ben Haynor's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -74.75% per trade.
---